130 related articles for article (PubMed ID: 10596853)
1. 5-hydroxytryptamine release from skin mast cells in vivo induced by peptide but not by nonpeptide ligands for bradykinin receptors.
Griesbacher T; Rainer I
Immunopharmacology; 1999 Sep; 43(2-3):195-201. PubMed ID: 10596853
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997.
Asano M; Hatori C; Sawai H; Johki S; Inamura N; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Mizutani T; Oku T; Nakahara K
Br J Pharmacol; 1998 Jun; 124(3):441-6. PubMed ID: 9647466
[TBL] [Abstract][Full Text] [Related]
3. Mediation by bradykinin of rat paw oedema induced by collagenase from Clostridium histolyticum.
Legat FJ; Griesbacher T; Lembeck F
Br J Pharmacol; 1994 Jun; 112(2):453-60. PubMed ID: 7915609
[TBL] [Abstract][Full Text] [Related]
4. Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.
Meini S; Patacchini R; Lecci A; Quartara L; Maggi CA
Eur J Pharmacol; 2000 Dec; 409(2):185-94. PubMed ID: 11104833
[TBL] [Abstract][Full Text] [Related]
5. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
[TBL] [Abstract][Full Text] [Related]
6. The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors.
Meini S; Lecci A; Maggi CA
Br J Pharmacol; 1996 Apr; 117(8):1619-24. PubMed ID: 8732268
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of B1 receptor mediating des-Arg9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin.
Campos MM; Souza GE; Calixto JB
Br J Pharmacol; 1996 Mar; 117(5):793-8. PubMed ID: 8851492
[TBL] [Abstract][Full Text] [Related]
8. Characterization of non-peptide bradykinin B2 receptor agonist (FR 190997) and antagonist (FR 173657).
Gobeil F; Montagne M; Inamura N; Regoli D
Immunopharmacology; 1999 Sep; 43(2-3):179-85. PubMed ID: 10596851
[TBL] [Abstract][Full Text] [Related]
9. Bradykinin B2 receptors and coupling mechanisms in the smooth muscle of the guinea-pig taenia caeci.
Field JL; Butt SK; Morton IK; Hall JM
Br J Pharmacol; 1994 Oct; 113(2):607-13. PubMed ID: 7834214
[TBL] [Abstract][Full Text] [Related]
10. The nonpeptide B2 receptor antagonist FR173657: inhibition of effects of bradykinin related to its role in nociception.
Griesbacher T; Amann R; Sametz W; Diethart S; Juan H
Br J Pharmacol; 1998 Jul; 124(6):1328-34. PubMed ID: 9720808
[TBL] [Abstract][Full Text] [Related]
11. Involvement of B1 and B2 receptors in bradykinin-induced rat paw oedema.
Campos MM; Calixto JB
Br J Pharmacol; 1995 Mar; 114(5):1005-13. PubMed ID: 7780633
[TBL] [Abstract][Full Text] [Related]
12. Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse.
Corrêa CR; Calixto JB
Br J Pharmacol; 1993 Sep; 110(1):193-8. PubMed ID: 8220879
[TBL] [Abstract][Full Text] [Related]
13. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H
Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388
[TBL] [Abstract][Full Text] [Related]
14. Proinflammatory characteristics of a nonpeptide bradykinin mimic, FR190997, in vivo.
Hayashi I; Ishihara K; Kumagai Y; Majima M
Br J Pharmacol; 2001 Aug; 133(8):1296-306. PubMed ID: 11498515
[TBL] [Abstract][Full Text] [Related]
15. In various tumour cell lines the peptide bradykinin B(2) receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist.
Drube S; Liebmann C
Br J Pharmacol; 2000 Dec; 131(8):1553-60. PubMed ID: 11139431
[TBL] [Abstract][Full Text] [Related]
16. The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657.
Asano M; Inamura N; Hatori C; Sawai H; Fujiwara T; Katayama A; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Nakahara K; Oku T; Okuhara M
Br J Pharmacol; 1997 Feb; 120(4):617-24. PubMed ID: 9051299
[TBL] [Abstract][Full Text] [Related]
17. Effects of FR173657, a non-peptide B2 antagonist, on kinin-induced hypotension, visceral and peripheral oedema formation and bronchoconstriction.
Griesbacher T; Legat FJ
Br J Pharmacol; 1997 Mar; 120(5):933-9. PubMed ID: 9138701
[TBL] [Abstract][Full Text] [Related]
18. Human vascular kinin receptors of the B2 type characterized by radioligand binding.
Gessi S; Rizzi A; Calò G; Agnello G; Jorizzo G; Mollica G; Borea PA; Regoli D
Br J Pharmacol; 1997 Dec; 122(7):1450-4. PubMed ID: 9421294
[TBL] [Abstract][Full Text] [Related]
19. Bradykinin B1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis.
Butt SK; Dawson LG; Hall JM
Br J Pharmacol; 1995 Feb; 114(3):612-7. PubMed ID: 7735687
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of the bradykinin B2 receptor: inter-species variability and dissociation between binding and functional responses.
Paquet JL; Luccarini JM; Fouchet C; Defrêne E; Loillier B; Robert C; Bélichard P; Cremers B; Pruneau D
Br J Pharmacol; 1999 Mar; 126(5):1083-90. PubMed ID: 10204994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]